SPP1 Marks Cross-Disease Microglial Activation in Neurodegeneration
A 2026 Glia analysis found a shared microglial transcriptional program across 5 neurodegenerative contexts: ALS, frontotemporal dementia, Alzheimer’s disease, aging, and Parkinson’s disease.…
Read article